Efficacy and safety of cerivastatin, 0.2 mg and 0.4 mg, in patients with primary hypercholesterolaemia: a multinational, randomised, double-blind study. Cerivastatin Study Group. [electronic resource]
Producer: 20000120Description: 228-40 p. digitalISSN:- 0300-7995
- Adult
- Aged
- Analysis of Variance
- Cholesterol -- blood
- Cholesterol, LDL -- drug effects
- Consumer Product Safety
- Diet
- Dose-Response Relationship, Drug
- Double-Blind Method
- Exercise
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Hypercholesterolemia -- drug therapy
- Least-Squares Analysis
- Male
- Middle Aged
- Pyridines -- administration & dosage
- Triglycerides -- blood
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.